Vivani Medical Inc is a preclinical-stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VANI is expected to report earnings to fall 9.09% to -10 cents per share on May 19
Q1'25
Est.
$-0.10
Q4'24
Est.
$-0.11
Q3'24
Missed
by $0.01
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.02
The last earnings report on March 31 showed earnings per share of -10 cents, meeting the estimate of -10 cents. With 98.73K shares outstanding, the current market capitalization sits at 67.27M.